At an 11-Year Low with a 4.9% Dividend Yield, Is This Value Stock a No-Brainer Buy for Passive Income in 2026?
Jan 11, 2026 by Courtney CarlsenThe Smartest Space Stocks to Buy With $2,000 Right NowAs investment dollars flow into space, these stocks offer a chance to capture the upside of a multidecade growth cycle.
Jan 11, 2026 by Reuben Gregg BrewerIs Ultra-High-Yield Enterprise Products Partners Your Ticket to Becoming a Millionaire?Enterprise Products Partners boasts a huge 6.8% yield and a reliable distribution history, but it is a slow and steady tortoise.
Jan 11, 2026 by Geoffrey Seiler3 Millionaire-Maker Technology Stocks Worth a LookThese high-risk, high-reward stocks could generate huge gains if they can become market leaders in their respective fields.
Jan 11, 2026 by Courtney CarlsenThe Smartest Space Stocks to Buy With $2,000 Right NowAs investment dollars flow into space, these stocks offer a chance to capture the upside of a multidecade growth cycle.
Jan 11, 2026 by Reuben Gregg BrewerIs Ultra-High-Yield Enterprise Products Partners Your Ticket to Becoming a Millionaire?Enterprise Products Partners boasts a huge 6.8% yield and a reliable distribution history, but it is a slow and steady tortoise.
Jan 11, 2026 by Jonathan PoncianoWhat Investors Should Know About a $163K AnaptysBio Insider SaleThis clinical-stage biotech specializing in antibody therapeutics reported a notable insider sale amid ongoing development and partnerships.
Jan 11, 2026 by Steven PorrelloIs It Too Late to Buy Oklo Stock?Oklo has already surged 260% year over year. Has the buying window closed?
Jan 11, 2026 by Jonathan PoncianoWhat Investors Should Know About a $520K Evolv CEO Stock Sale as Shares Jump 130%This AI-driven security firm, known for touchless screening systems, reported a notable insider sale amid strong one-year share gains.
Jan 11, 2026 by Thomas NielIs This Once-Hyped Stock Finally Worth a Second Look?Recent housing market-related news may open the door to an Opendoor Technologies rebound.
Jan 11, 2026 by Neil PatelIs Ford Stock a Millionaire-Maker?After a huge year, shareholders in the Detroit car company are ready for more gains.
Jan 11, 2026 by Keithen Drury3 Absurdly Cheap Stocks That Could Double in 2026The market wasn't kind to this trio in 2026.
Jan 11, 2026 by Brett SchaferWhy This Gold Mining Stock Was Up Close to 1,000% Last YearThe speculative gold and silver miner is benefiting from rising commodity prices.
Jan 11, 2026 by James HiresDo You Own Energy Fuels Inc. Stock? Take a Look at This Stock Instead.Energy Fuels is America's largest uranium producer, but there's a far bigger fish up north.
Jan 11, 2026 by Jennifer SaibilThis Bank Stock Could Be One of the Best Companies to Own in 2026All of its segments are thriving.
Jan 11, 2026 by Thomas NielCan These 3 Companies Turn the Prediction Market Sector Into Serious Profit?Can market incumbents in sports betting and financial services take on first-movers like Kalshi and Polymarket?
Jan 11, 2026 by Brett SchaferWhy e.l.f. Beauty Stock Collapsed 40% In 2025The company's revenue growth is slowing as the stock trades at a premium price.
Jan 11, 2026 by Geoffrey Seiler3 Millionaire-Maker Technology Stocks Worth a LookThese high-risk, high-reward stocks could generate huge gains if they can become market leaders in their respective fields.
Jan 11, 2026 by Keith NoonanWhy Redwire Stock Skyrocketed 37.9% Last Month and Has Kept Soaring in 2026Redwire stock is heating up thanks to bullish news for the space industry.
Jan 11, 2026 by Prosper Junior BakinyThis Healthcare Stock Could Be One of the Best Companies to Own in 2026It has strong momentum thanks to its current portfolio and several catalysts on the horizon.
Jan 11, 2026 by Jonathan PoncianoUrban Outfitters Insider Sells Another $1.5 Million in Stock as Shares Climb 43% in a YearThis lifestyle retailer behind brands like Anthropologie and Free People reported a notable insider sale, according to recent SEC filings.
Jan 11, 2026 by Reuben Gregg BrewerIs Energy Transfer Stock a Buy Now?Energy Transfer has a huge 7.8% yield, but is it the best midstream income option for your portfolio?
Jan 11, 2026 by Lawrence Rothman, CFASpyre Therapeutics' CEO Sells 15,000 SharesThis biotech innovator in antibody therapies for inflammatory bowel disease reported a notable insider sale, according to a recent SEC filing.
Jan 11, 2026 by Maurie BackmanThe 1 Thing About Social Security Spousal Benefits All Married Retirees Need to KnowMake sure you understand a key rule.
